Taiwan draws foreign biotech IPOs

Aslan had weighed a US IPO, among various options … The company will continue to be headquartered in Singapore but has invested in expanding in Taiwan. Aslan’s experimental drug Varlitinib, a potential treatment for bile duct cancer, is in late …
( read original story …)


Related Post